Want to see IT:SOL full AI Analyst Report?
Top Page
SOL SPA
(SOL)
Select Model
Select Model
Rating:56Neutral
Price Target:
€58.00
▼(-7.79% Downside)
Action:Reiterated
Date:08/04/26
The score is primarily supported by solid operating performance and consistent growth, but is pulled down by weak cash-flow quality (declining free cash flow) and a materially weak technical setup. A relatively high P/E and low dividend yield further reduce valuation support.
Positive Factors
Consistent Revenue Growth
Sustained annual revenue growth from 2020–2025 indicates durable demand for the company’s specialty-chemicals portfolio and supports investment capacity. Reliable top-line expansion across cycles underpins long-term planning, capacity utilization, and incremental margin recovery opportunities.
Negative Factors
Declining Free Cash Flow
A falling free-cash-flow trend reduces financial flexibility for dividends, buybacks, or deleveraging. If capex or working-capital needs remain elevated, the company may have less capacity to fund growth or absorb shocks, raising longer-term funding and execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Sustained annual revenue growth from 2020–2025 indicates durable demand for the company’s specialty-chemicals portfolio and supports investment capacity. Reliable top-line expansion across cycles underpins long-term planning, capacity utilization, and incremental margin recovery opportunities.
Read all positive factors
SOL SPA (SOL) vs. iShares MSCI Italy ETF (EWI)
Market Cap
€5.16B
Dividend Yield0.79%
Average Volume (3M)31.19K
Price to Earnings (P/E)30.9
Beta (1Y)0.46
Revenue Growth10.29%
EPS Growth13.07%
CountryIT
Employees7,100
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)1.84
Shares Outstanding90,700,000
10 Day Avg. Volume35,913
30 Day Avg. Volume31,190
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)3.91
Price to Sales (P/S)2.50
P/FCF Ratio178.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€60.00Price Target Upside-4.61% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)2.08
Revenue Forecast (FY)€1.92B
SOL SPA Business Overview & Revenue Model
Company Description
SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and med...
SOL SPA Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
67
Positive
Cash Flow
52
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.78B | 1.61B | 1.49B | 1.38B | 1.11B |
| Gross Profit | 292.90M | 1.17B | 641.49M | 290.04M | 250.18M |
| EBITDA | 439.84M | 391.08M | 372.51M | 319.04M | 255.41M |
| Net Income | 166.99M | 147.70M | 145.73M | 133.69M | 89.55M |
Balance Sheet | |||||
| Total Assets | 2.42B | 2.14B | 1.94B | 1.72B | 1.44B |
| Cash, Cash Equivalents and Short-Term Investments | 364.71M | 244.14M | 220.15M | 147.43M | 139.64M |
| Total Debt | 828.83M | 573.61M | 620.54M | 461.36M | 460.40M |
| Total Liabilities | 1.23B | 1.06B | 965.54M | 855.95M | 723.00M |
| Stockholders Equity | 1.14B | 1.03B | 928.61M | 820.62M | 698.26M |
Cash Flow | |||||
| Free Cash Flow | 24.88M | 47.43M | 65.11M | 53.74M | 44.81M |
| Operating Cash Flow | 276.77M | 297.49M | 270.06M | 214.92M | 192.56M |
| Investing Cash Flow | -286.67M | -266.37M | -246.69M | -252.30M | -229.52M |
| Financing Cash Flow | 120.05M | -7.88M | 52.42M | 30.34M | -93.53M |
SOL SPA Technical Analysis
Negative
62.90
Price Trends
59.52
Negative
57.87
Negative
53.29
Positive
Market Momentum
-0.44
Positive
35.19
Neutral
5.92
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:SOL, the sentiment is Negative. The current price of 62.9 is above the 20-day moving average (MA) of 60.39, above the 50-day MA of 59.52, and above the 200-day MA of 53.29, indicating a neutral trend. The MACD of -0.44 indicates Positive momentum. The RSI at 35.19 is Neutral, neither overbought nor oversold. The STOCH value of 5.92 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IT:SOL.
SOL SPA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | €99.52B | 27.22 | 12.65% | 3.71% | -3.07% | -42.04% | |
61 Neutral | €4.48B | 6.36 | 18.08% | 4.41% | -20.70% | 83.10% | |
58 Neutral | €5.55B | 11.85 | 11.63% | 4.08% | -11.37% | -8.40% | |
56 Neutral | €5.16B | 30.92 | 15.43% | 0.72% | 10.29% | 13.07% | |
56 Neutral | €7.11B | 10.46 | 12.19% | 4.42% | 13.73% | -15.88% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IT:SOL
SOL SPA
56.70
8.37
17.32%
IT:A2A
A2A SpA
2.30
0.23
11.06%
IT:ACE
ACEA SPA
21.04
2.16
11.44%
IT:EDNR
Edison Spa
1.91
-0.21
-9.69%
IT:ENEL
Enel S.p.A.
9.91
2.51
33.86%
IT:HER
HERA S.p.A.
3.87
0.25
6.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.